Aptose Biosciences Inc. - APTOF
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2025
· Q4 2024
Value (USD)
Total reported value ($000)
$102K
QoQ value delta ($000)
-$207K
(-66.99%)
Implied price effect (QoQ)
+1276.23%
Shares
Total shares
33,173
QoQ shares delta
-1,349,862
(-97.6%)
Total shares held by funds (by quarter)
Market chart (APTOF)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2025)
Top 25 only
Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Sigma Planning Corp | 54 | 17,389 | 0.0% |
| CITADEL ADVISORS LLC | 38 | 12,007 | 0.0% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 6 | 2,060 | 0.0% |
| ROYAL BANK OF CANADA | 4 | 1,351 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 36 | 0.0% |
| DANSKE BANK A/S | 0 | 4 | 0.0% |
| MORGAN STANLEY | 0 | 101 | 0.0% |
| NATIONAL BANK OF CANADA /FI/ | 0 | 93 | 0.0% |
| GROUP ONE TRADING LLC | 0 | 3 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 4 | 0.0% |
| TD Waterhouse Canada Inc. | 0 | 22 | 0.0% |
| Federation des caisses Desjardins du Quebec | 0 | 103 | 0.0% |